STAT’s First Opinion podcast host Torie Bosch talks with two abortion providers about what it’s like to practice medicine in post-Roe America.
Dan Gorenstein
Dan is the Founder and Executive Editor of Tradeoffs, setting the vision for the organization’s journalism and strategy. Before Tradeoffs, he was the senior health care reporter at Marketplace and spent 11 years at New Hampshire Public Radio. He got his start in journalism at the Chicago Reporter, an investigative journal that examines race and class disparities in the Chicago area. Dan’s work has earned numerous national awards, including the Society of Professional Journalists Sigma Delta Chi investigative reporting award. He is based in Philadelphia.
When Research and the Realities of Practicing Medicine Collide
Tradeoffs research reporter Soleil Shah shares what he’s learning as a new medical resident about the value and limitations of health policy research.
Medicare Releases Details of Major Drug Price Reform
Medicare’s historic plan to slow prescription drug spending is taking shape.
Data and Door Knocking: One City’s Push for Racial Equity in Vaccines
What Chicago can teach the rest of the country about distributing vaccines more equitably.
The High Price of Lowering Health Costs for 150 Million Americans
Employers clash with hospitals, insurers and even their own workers over high health care prices.
Primary Care in Crisis
The coronavirus pandemic is putting a serious strain on the country’s primary care system.
Coronavirus Conversations: The Social Distance Social
Dan joins a group of neighbors for their “social distance” stoop party and hears how they are experiencing this outbreak so far.
‘Hot Spotters’ on Trial
Improving health and lowering costs for the sickest and most expensive patients in America is a dream harder to realize than many health care leaders had hoped.
The Sidebar: Randomized Controlled Trials (RCT)
Randomized controlled trials (RCTs) are often viewed as the “gold standard” of health care research. How do they work and what are their tradeoffs?
The Good Stuff
Two friends—a doctor and an economist—have spent more than 20 years trying to redesign insurance around one simple but elusive goal: make the good stuff more accessible than the bad stuff.
